retatrutide and addiction Five Treatments That Might Actually Work: A 2025 Assessment Retatrutide, an experimental weight-loss drug,

Effective strategies promote long-term success with weight loss or diabetes care

That third receptor, glucagon, is the key differentiator

Most people experience mild nausea in the early weeks, especially during dosage increases

Individual responses to medication vary, and management strategies should be tailored to your specific situation

The Wegovy pill is FDA-approved for: Weight loss in adults with obesity or overweight with at least one weight-related health condition (such as type 2 diabetes or obstructive sleep apnea) in adults with heart disease and obesity or overweight Cardiovascular risk reduction Like Rybelsus, Wegovy follows a dosage titration schedule